Bausch Health Companies Inc. (NASDAQ:BHC) | WebDisclosure

Basculer en Français

9479	Companies
185505	Keywords
117891	Articles
99360	Press releases

Headlines Articles Press releases Bausch Health Companies Inc.

Home
Companies
Bausch Health Companies Inc.

PRESS RELEASE

published on 07/10/2025 at 23:00, 4 months 25 days ago

CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs
Bausch Health, Canada introduces CABTREO gel for acne treatment to public drug plans in Ontario, Nova Scotia, and federal programs, expanding access for Canadians

Bausch Health Health Canada Approval Acne Treatment Public Drug Plans CABTREO Gel
BRIEF

published on 07/10/2025 at 22:20, 4 months 25 days ago

Bausch Health nomme Steven Lee au poste de directeur comptable

Bausch Santé Rapports Financiers Steven Lee Société Pharmaceutique Chef Comptable
BRIEF

published on 07/10/2025 at 22:20, 4 months 25 days ago

Bausch Health Appoints Steven Lee as Chief Accounting Officer

Pharmaceutical Company Financial Reporting Bausch Health Steven Lee Chief Accounting Officer
PRESS RELEASE

published on 07/10/2025 at 22:15, 4 months 25 days ago

Bausch Health Appoints New Chief Accounting Officer
Bausch Health Companies Inc. appoints Steven Lee as Senior Vice President, Controller, and Chief Accounting Officer. Steven brings extensive financial experience for long-term value

Bausch Health Steven Lee Financial Transformation Controller Chief Accounting Officer
BRIEF

published on 07/09/2025 at 14:05, 4 months 27 days ago

Bausch Health lance CABTREO pour le traitement de l'acné au Canada

CABTREO Canada Bausch Santé Traitement De L'acné Régimes Publics D'assurance-médicaments
BRIEF

published on 07/09/2025 at 14:05, 4 months 27 days ago

Bausch Health Launches CABTREO for Acne Treatment in Canada

Bausch Health CABTREO Canada Acne Treatment Public Drug Plans
PRESS RELEASE

published on 07/09/2025 at 14:00, 4 months 27 days ago

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs
Bausch Health Canada Inc. launches CABTREO triple-combination gel for acne vulgaris, now accessible through public drug plans in Ontario, Nova Scotia, and federal government programs

Bausch Health CABTREO Acne Vulgaris Health Canada Topical Treatment
PRESS RELEASE

published on 07/09/2025 at 14:00, 4 months 27 days ago

Le traitement pour l’acné vulgaire de Bausch Health, Canada Inc., (Pr)CABTREO(MC) (gel de phosphate de clindamycine, d’adapalène et de peroxyde de benzoyle), est maintenant couvert par les régimes publics de l’Ontario, de la Nouvelle Écosse et p
Bausch Health Canada lance CABTREO, un nouveau gel topique \/ acné vulgaire. Disponible via assurance-médicaments en Ontario, Nouvelle-Écosse et pour les Premières Nations. Traitement triple combinaison approuvé par Santé Canada

CABTREO Santé Canada Bausch Health Canada Traitement Topique Acné Vulgaire
BRIEF

published on 07/07/2025 at 14:05, 4 months 29 days ago

La campagne de Bausch Health vise à informer sur le Xifaxan pour le traitement de l'encéphalopathie hépatique

Salix Pharmaceuticals Autonomisation Des Patients Encéphalopathie Hépatique Campagne Xifaxan Éducation Sur Les Maladies Du Foie
BRIEF

published on 07/07/2025 at 14:05, 4 months 29 days ago

Bausch Health’s Campaign Aims to Educate on Xifaxan for Hepatic Encephalopathy

Salix Pharmaceuticals Patient Empowerment Hepatic Encephalopathy Xifaxan Campaign Liver Disease Education

Accesswire

Published on 12/05/2025 at 17:15, 32 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 47 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 47 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 2 hours 2 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 2 hours 2 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 47 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 22 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 37 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 47 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 47 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 17:18, 29 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 29 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 36 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 36 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 49 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE